Adoptive transfer of T lymphocytes is an attractive strategy for many experimental treatment strategies for cancer. Unfortunately, manipulated T cells could be responsible for serious adverse events. Retroviral CD20-transduced T cells may be able to control these unwanted effects. CD20-positive cells are sensitive to rituximab (RTX), a monoclonal antibody specific for CD20. This permits their selective elimination in vivo in case of adverse events. To this end, a system is required that permits efficient and safe transduction of donor T cells and effective elimination of CD20-positive T cells. We constructed different CD20-encoding retroviral vectors and investigated the impact of inclusion of the woodchuck posttranscriptional regulatory element (WPRE) and the chicken hypersensitivity site 4 insulator elements on the levels, homogeneity and stability of CD20 expression. Importantly, inclusion of either WPRE or insulator elements in the retroviral vector resulted in a dramatic improvement in the stability of CD20 expression. The insulator element also led to a much more homogeneous level of CD20 expression. We also show the efficient elimination of the CD20-transgenic T cells via RTX by different effector mechanisms. In conclusion, we have constructed CD20-encoding retroviral vectors with improved efficiency and safety profiles, which can be used as a suicide strategy. Gene Therapy (2006) 13, 789-797.
Introduction
Adoptive transfer of T lymphocytes is an attractive approach in many experimental treatment strategies for cancer. However, these therapeutic T cells could also be responsible for unwanted effects. For example, in haematology, allogeneic donor T cells may respond to the patient's own tissue resulting in the life-threatening complication graft versus host disease (GVHD). An innovative strategy to control these unwanted effects is the genetic manipulation of these donor T cells with a 'suicide' gene. Introduction of a suicide gene into these T cells prior to transplant allows their selective elimination in case of uncontrollable GVHD. 1, 2 Recently, the B-cellrestricted CD20 molecule has been proposed as a novel suicide gene. 3, 4 CD20-positive cells can be killed effectively via an anti-CD20 monoclonal antibody. Rituximab (RTX) is a monoclonal antibody that recognizes the human CD20 molecule and is joined to a human IgG1 constant region. This IgG1 region is responsible for the activation of the complement system (CDC) and the recruitment of effector cells (ADCC) to kill the RTXligated cells. It has also been shown that RTX can induce apoptosis and growth arrest of CD20-positive cells. [5] [6] [7] [8] Importantly, the CD20 molecule may also be used as a selection marker to purify CD20-transgenic cells, which obviates the need to include selection genes. 3, 4 For stable expression of a transgene in T cells, retroviral vectors are still the most effective tools. Particularly so, since most T cells proliferate vigorously after adoptive transfer, necessitating insertion of the transgene into the cell's genome. However, retroviral vectors also bear some disadvantages, for example, loss of transgene expression 9 and the potential activation of oncogenes. 10 Moreover, for efficient elimination of CD20-transgenic T cells, high CD20-expression level is necessary. 11 We now report the construction and analysis of a set of CD20-encoding retroviral vectors with various configurations. Two cis-acting elements were inserted into the vector in order to evaluate their effectiveness in mediating a homogeneous, stable, safe and high level of CD20 expression. The first is the woodchuck hepatitis post-transcriptional regulatory element (WPRE), which has been used widely in retroviral vectors and has been proven to increase transgene expression in different cell types in vitro and in vivo. Improved post-transcriptional processing, transport of mRNA from the nucleus to the cytoplasm and improved translation of the mRNA have been attributed to the activity of the WPRE element. [12] [13] [14] Secondly, we included insulator elements in the CD20 vectors. Chicken hypersensitive site 4 (cHS4) insulators have been used in retroviral vectors for the treatment of b-chain hemoglobinopathies for stable and long-term expression of the b-globin gene. Insulators protect retroviral transgene expression from position effects through definition of the boundary between differentially regulated loci. In addition, they shield promoters from the influence of neighboring regulatory elements and protect retroviral transgenes from silencing. Therefore, it is generally expected that insulators will also prevent oncogene activation following chromosomal insertion of a retrovirus. Insulators therefore represent an attractive safety tool for retrovirus-mediated gene therapy approaches. 13, [15] [16] [17] In this study, we demonstrate the importance of the WPRE and insulator elements for homogeneous, stable and high level expression of CD20. Moreover, we show for the first time that CD20-transgenic T cells can efficiently be killed via RTX by activating different human effector mechanisms.
Results

Construction of CD20-encoding retroviral vectors
CD20-encoding retroviral vectors were constructed to obtain a high, stable and homogeneous CD20 expression in T cells. The human CD20 cDNA was cloned into an MoMLV-based backbone under transcriptional control of the LTR promoter. A Kozak sequence was included within the first AUG codon of the CD20 gene to favor ribosome binding for the start of translation. 18 A second construct was made through insertion of the WPRE element downstream of the CD20 cDNA, resulting in the CD20W vector. A double copy of the 250 bp cHS4 insulator core element (ICE) or a single copy of the complete 1.2 kb cHS4 insulator element (INS) was inserted into the U3 region of the 3 0 LTR of the CD20-and CD20W vectors, resulting in the CD20-ICE, CD20-INS, CD20W-ICE and CD20W-INS vectors, respectively ( Figure 1 ). , n ¼ 8) transduction units (TU)/ml were obtained with both the CD20 and CD20W vectors. Inclusion of the insulator elements reduced the viral titers 2-6-fold, confirming previous observations (data not shown). 19, 20 To compare the level of CD20 expression provided by the individual constructs, the CD20-negative human T-cell line CEM was transduced in triplicate with each of the CD20-encoding vectors. For application of genemodified cells in clinical settings, it is desirable to minimize the number of viral integrations per cell, thereby reducing the chance of insertional mutagenesis. Therefore, we used an MOI of 1 in all experiments, routinely leading to transduction efficiencies of o30%, as expected 21 ( Figure 2a ). After transduction, CD20-positive cells were purified via immunomagnetic beads and kept in culture for at least 3 months. CD20 expression was studied by flow cytometry shortly after transduction, after immunomagnetic bead selection and after longterm culture. The level of CD20 expression is represented by the mean fluorescence intensity (MFI). Figure 2 displays a typical example of a transduction, purification and long-term culture of one experiment. Figure 3a shows the MFI of CEM cells transduced with the different CD20 vectors of three independent transduction experiments performed in triplicate. The analyses were restricted to the positive fraction only. The CD20 vector (MFI ¼ 386729) and the vectors containing the WPRE element, CD20W, CD20W-ICE and CD20W-INS, provided the highest level of CD20 expression (351766, 378742 and 309714, respectively). In contrast, the MFI of cells transduced with CD20-ICE and CD20-INS vectors were 2-3-fold reduced (19873 and 11871, respectively) compared with the CD20 vector (Po0.001). These data suggest that insulators alone exert a negative effect on the level of CD20 expression, confirming previous reports. 19, 20 The additional presence of the WPRE element seems to compensate for the negative insulator effect.
Viral titers and CD20-expression patterns
Homogeneity and stability of CD20 expression
The homogeneity of CD20 expression is represented by the coefficient of variation (CV), which represents the variability of CD20 expression within a given cell population. 19 Consequently, the lower the CV value, the more homogeneous the levels of CD20 expresssion. The CV values are represented by the mean7s.d. of three different transduction experiments performed in triplicate (Figure 3b ). Cells transduced with the CD20 vector displayed a broad CD20-expression pattern (CV ¼ 26.871.6). Inclusion of the WPRE element (CD20W) did not improve the homogeneity (CV ¼ 27.071.9). In contrast, a significant positive effect (Po0.001) on the CV value was observed in cells transduced with all vectors containing the insulator elements, compared to the CD20 vector. For the CD20-ICE and CD20-INS vectors, the CV values were 22.871.7 and 22.172.0, respectively. Inclusion of both the WPRE element and the insulator did not result in more homogeneous CD20-expression pattern, Figure 1 Schematic representation of the CD20 retroviral constructs. CD20 cDNA was cloned into the pMX backbone under transcriptional control of the MLV-LTR. The WPRE was inserted downstream of the CD20 cDNA. The 1.2 kb cHS4 insulator (INS) or the insulator core element (ICE) was inserted into the 3 0 U3 region.
Improved CD20 expression for efficient elimination of CD20-transgenic T cells T van Meerten et al compared with vectors containing the insulators but without the WPRE element (CV ¼ 22.571.9 for CD20W-ice and 21.071.9 for CD20W-INS. These results indicate that insulator elements lead to a more homogeneous CD20-expression pattern. The transduced cells were purified with immunomagnetic beads and after purification more than 95% of the cells expressed CD20. Shortly after selection, the MFI and CV value were analyzed. The second column in Figure 2 displays a typical example of the purification of transduced cells. The highest CD20-expression pattern was obtained with vectors containing the WPRE element compared with vectors lacking the WPRE element. The MFI value of cells transduced with insulator-containing vectors was significantly lower compared to CD20 and CD20W.
Next, we investigated the stability of CD20 expression. The purified cells were cultured for a period of 3 months after which the fraction of CD20-positive cells, MFI and the CV values were determined again ( Figure 2 , third column). CD20 expression was gradually lost in cells transduced with the CD20 vector. Only 42% of the cells displayed CD20 expression after continued culture for 3 months. A loss in CD20 expression, albeit low (5%), was observed in cells transduced with CD20W as well. In contrast, cells transduced with vectors containing the insulator elements maintained CD20 expression after culture, indicating that insulators prevent a temporal loss in CD20 expression in T-cell lines. No difference in homogeneity of CD20 expression was observed in cells transduced with CD20 or CD20W. However, cells transduced with vectors containing the insulators provided an even more homogeneous CD20 expression. The most homogeneous CD20 expression was obtained with cells containing CD20W-INS (CV ¼ 12.5). Together, these data demonstrate that the WPRE fragment increases Improved CD20 expression for efficient elimination of CD20-transgenic T cells T van Meerten et al expression of the transgene, i.c. CD20, in T cells. Moreover, the inclusion of insulator elements alone has a profound effect on the homogeneity and stability of expression.
Evaluation of the sensitivity of RTX-mediated killing of CD20-transgenic CEM cells
To study whether CD20-transgenic T cells are sensitive to RTX and its mechanisms, we subjected the cells to human complement and effector cells. CEM cells were transduced with the CD20 vector, selected and used within 2 weeks of cultering. All cells express CD20 and for the CDC assays, we used human serum as complement source and rabbit serum as positive control. As shown in Figure 4 , maximum lysis is achieved at a minimum of 10 mg/ml RTX (Figure 4a ), 25% of human serum ( Figure 4b ) and after 1 min at 371C (Figure 4c) .
To investigate the optimal condition for RTX to activate effector cells, we titrated the concentration of antibody, target-effector cell ratio and incubation time. The experiment was performed in triplicate and each bar represents the mean7s.d. Figure 5 displays the results of CEM-CD20 cells with or without RTX and IL-2-stimulated PBMCs as effector source. The surviving cells were counted after 4 h and the results were expressed as percentage of the RTX-untreated cells. Increasing the concentration of RTX (0.1 mg/ml to 100 mg/ml) had little effect on the effector function of the PBMCs towards CEM-CD20 cells. However, using more effector cells resulted in more RTX-mediated cell kill. A maximum of 22% cell survival was obtained with 100 mg/ml of RTX with a target to effector ratio of 1:30. Increasing the incubation time did not result in more RTX-mediated killing of CEM-CD20 cells (Figure 5b ). No direct effect of 6 CEM-CD20 cells were resuspended in 50% of serum, as a complement source, to a final concentration of 1 ml. The cells were kept at 371C for 1 h. Different concentrations of antibody were added. As a positive control, rabbit serum was used and as negative control heat-inactivated sera. (b) Titration of the minimal concentration of human serum needed for optimal killing of CEM-CD20 cells. 1.0 Â 10 6 CEM-CD20 cells were incubated with 10 mg/ml of RTX and resuspended in different concentrations of serum to a final concentration of 1 ml. The cells were kept at 371C for 1 h. As a positive control, rabbit serum was used. (c) Time course of RTXinduced CDC on CEM-CD20 cells. CEM-CD20 cells were incubated with 10 mg/ml and resuspended in 1 ml medium containing 25% serum. Cells were incubated at 371C for various time points. Propidium iodide exclusion was used to determine the level of cell kill. 
RTX in proliferation or induction of apoptosis was observed in our experiments (data not shown).
Complete elimination of CEM-CD20 cells was not obtained with either CDC or ADCC alone. To obtain maximum kill, we combined the two effector mechanisms of RTX. In this assay, 10 mg/ml RTX was used, with 50% human serum and 1:10 target-effector cell ratio. After incubation of the cells for 4 h at 371C, the surviving cells were counted and results were expressed as percentage of the RTX-untreated cells. Figure 6 shows a representative example of the direct effect of RTX, activation of effector cells, CDC activity and the combined activity of both mechanisms. Again, no decrease in cell numbers was observed with RTX alone. With ADCC alone, 67.8713.7% of the cells were killed and with CDC this was 69.573.3%. Combining both effector mechanisms did lead to an increase in cell kill (Po0.001), 28.673.9% of the cells survived in this assay. These data suggest that the effector mechanisms act complementary.
To study whether the bulk transduced cells with the different constructs (CD20, CD20W, CD20-ICE and CD20W-ICE) were sensitive to RTX and its effector mechanisms or whether one of the vectors resulted in better cell kill, we employed these cells in the same killing assay (Figure 7) . The ADCC activity (1:20 target:effector ratio) of RTX is displayed in Figure 7b and no major differences were observed in cell survival that ranged from 13.271.1 to 25.571.4%. In contrast, for CDC (Figure 7c ), differences were observed in RTXinduced cell kill between the cells transduced with the different constructs, only cells transduced with CD20-ICE vector were significantly less sensitive to RTX and complement compared to CD20 alone. The cell survival of CEM-CD20 was 43.171.2%, CEM-CD20W 47.573.8%, CEM-CD20-ICE 62.473.5% and for CEM-CD20W-ICE the cell survival was 36.172.0%. Finally, we combined the effector mechanisms and again the cell survival was significantly decreased to 6.371.4, 11.373.1, 9.971.8 and 8.772.0% for CEM-CD20, CEM-CD20W, CEM-CD20-ICE and CEM-CD20W-ICE, respectively (Figure 7d ). There was no significant difference in the killing efficiency of the CD20-transduced cells compared to the improved CD20-encoding retroviral vectors. These data clearly show for the first time that CD20-transgenic T cells can be efficiently eliminated by RTX via activation of different effector mechanisms of human origin.
Discussion
The success of any suicide system depends on the effectiveness of selective elimination of the desired cell type. Selectivity is achieved by the enforced, unique expression of a particular protein that renders the cell sensitive toward the eliminating reagent. In the case of the CD20/aCD20 system, selectivity is achieved through ex vivo transduction of T cells with a recombinant retrovirus encoding the CD20 transgene that is normally not expressed on T cells, but only on B cells. Thus, unmanipulated T cells will remain insensitive toward CD20-targeting reagents, such as the human-mouse chimeric Ab RTX. As a side effect, patient's B cells will be eliminated at the same time. However, plasma cells, which are CD20 negative, will be preserved ensuring continuous production of serum immunoglobulin.
Retroviruses are still the favorite tools for genetic modification of T cells, despite their involvement in oncogenesis when used under certain circumstances to modify hematopoietic progenitor cells. 10, 22 Nevertheless, also for modification of T cells caution is still warranted 
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and safer vector configurations are desirable. We therefore evaluated the impact of the WPRE and insulator elements on transgene-expression in human T cells. We also explored the efficacy of RTX-induced cell kill of CD20-expressing T cells with effector mechanisms of human origin.
RTX has been shown to activate different effector mechanism for the elimination of CD20-positive cells leading to death of the cell. RTX alone or crosslinking of RTX did not directly kill the CEM-CD20 transgenic T cells nor was their proliferation inhibited. In vitro and in vivo data have clearly demonstrated that RTX recruits FcgR-expressing effector cells. 23, 24 Consistent with these observations, CEM-CD20 cells were lysed efficiently by activated PBMCs in the presence of RTX. It remains to be seen to what extent these in vitro findings correlate with the contribution of effector cells in in vivo clearance of CD20-expressing cells. Nevertheless, these ADCC experiments demonstrate that CD20-positive T cells can be eliminated efficiently by effector cells via RTX.
As with ADCC, CEM-CD20 transgenic T cells were also sensitive to human serum. Rabbit serum was used as a positive control and was much stronger in inducing cell kill than human serum. However, we show that human serum can kill significant numbers of cells. Importantly, CEM-CD20 cells with higher CD20-expression level were more sensitive to RTX compared to cells with lower MFI, confirming previous observations with fresh tumor material of B-cell origin. 11 Combining CDC and ADCC did lead to almost complete elimination of CD20-positve T cells. An additive effect of both CDC and ADCC has been described previously in RTX-mediated killing experiments on fresh B-cell leukemia samples. 25 In an attempt to positively influence CD20 expression, the WPRE element was inserted downstream of the CD20 cDNA. The WPRE element has been widely proven to enhance transgene expression under control of several different promoters and in different cell lineages. 13, 14 Its exact mode of action is unclear, but it has been suggested that the WPRE element acts on both the transcriptional and translational level. It promotes mRNA transport from the nucleus to the cytoplasm, and may facilitate protein expression from mRNAs that normally would be degraded within the nucleus. [12] [13] [14] In our hands, the WPRE element had only a minor positive effect on the level of CD20 expression. Surprisingly, a profound effect of the WPRE element was observed on the stability of CD20 expression in CEM cells after selection and continued culture for 3 months. These findings indicate that the WPRE element is a useful component in CD20-encoding retroviral vectors. Recently, suspicions have been raised with regard to the potential oncogenicity of the truncated X protein that is encoded within the WPRE. 26 Although our constructs encode the non-carcinogenic full-length X protein, we cannot exclude the possibility at this stage that mutant X protein-expressing cells may arise in vivo and exhibit a selective growth advantage. As the effects of truncated X proteins have been studied in liver cells only, the relevance of these findings for other cell types is presently unknown. 27, 28 Of note, the recently published MP71 vector did not give a higher CD20 expression in our hands (data not shown). 29 Apparently, for expression of heterologous genes in human T cells, pMX is already a much better vector than LGSN, which seems to give a relatively low GFP expression, compared to pMX-EGFP vectors (data not shown). The WPRE element has often been coupled to EGFP expression for enhancement of expression in T cells and others cell types.
14,29 CD20 expression has also been shown with vectors containing CD20 and the WPRE element in T cells. 30 However, in this report, two lentiviral constructs with two different promoters were compared, both vectors containing the WPRE element. So, the effect on CD20 expression with or without the WPRE element was not compared in this report.
The recent development of leukemia in three patients who had received retrovirally modified hematopoietic progenitor cells proved the, till then theoretical, risk of insertional mutagenesis to be real. 10, 31, 32 Insertional mutagenesis by a recombinant retrovirus has also been observed after retroviral modification of murine hematopoietic progenitor cells. 22 In response to these observations, the inclusion of insulators has been postulated to increase the safety of retroviral constructs. 33 Insulators are currently used in retroviral vectors for the treatment of g-globin deficiencies and have been shown to reduce position effects and protect transgene expression from silencing. Insulators also have shielding capacity and block transgene expression by interfering with promoterenhancer activity. As a consequence, insulators reduce the influence of neighboring promoters/enhancers on transgene expression and provide a more homogeneous transgene expression. 12, 13, 17, 19, 20, 34, 35 Theoretically, insulators will therefore also protect from oncogene activation by chromosomal insertion of the retrovirus, although this assumption still awaits formal proof. Our experiments clearly demonstrate that both the full-length 1.2 kb insulator as well as the double copy of the insulator core element had a profound effect on the homogeneity of the CD20-expression level. These observations indicate that both elements are fully functional in T cells and support their incorporation in future vectors. Obviously, their capacity to truly prevent insertional mutagenesis needs to be assessed empirically in in vivo experiments. To our knowledge, this is the first time that insulators have been employed successfully in T lymphocytes. We expect that the use of insulators in combination with low MOI will minimize the chance of insertional mutagenisis. 21 Although the insulators resulted in an increased homogeneity of CD20-expression, they also led to a decrease in viral titer and CD20-expression level. This is consistent with published data. 19, 20 This phenomenon may be explained by prevention of the effect of endogenous enhancers on the internal promoters. In our experiments, the simultaneous inclusion of WPRE compensated this effect. The enhanced RNA processing of the WPRE element could explain the compensated loss of CD20 expression. The loss may be caused by the blocking of endogenous promoters and/or enhancers. Of course, this is speculative and needs further demonstration. If future experiments confirm the risks associated with the use of the WPRE fragment in an interferon-b scaffold attachment region (IFN-SAR), which reportedly increased the transgene expression, may be included instead in insulator-containing constructs. 19, 36 In summary, we have generated safe CD20-encoding retroviral vectors that permit the generation of CD20-positive T cells at an MOI of 1 that can be killed efficiently via RTX in the presence of human complement Improved CD20 expression for efficient elimination of CD20-transgenic T cells T van Meerten et al and effector cells. Previously, it has been shown that the complete insulator element and a double copy of the insulator core element function equally well in erythroid cells. Our data now extend these findings to human T cells.
Materials and methods
Subcloning of the CD20 cDNA and the WPRE fragment
The human CD20 cDNA was amplified by PCR from the pCMV-CD20-expression vector, and the WPRE fragment was amplified from the pSFb-EGFP-WPRE retroviral vector, 35 by using the following primers: CD20 FW 5 0 -GGG CCG CGG CCG CCG CCA TGA CAA CAC CCA GAA ATT CAG TA-3 0 (Kozak-sequence underlined); CD20-SalI RV 5 0 -GGG GTC GAC AAA TCA CTT AAG GAG AGC TGT CAT-3 0 ; CD20-NotI RV 5 0 -GGG GCG GCC GCA AAT CAC TTA AGG AGA GCT GTC AT-3 0 ; WPRE-NotI FW 5 0 -GCG GCC GCG AAT TCG AGC ATC TTA CCG CCA T-3 0 ; WPRE-SalI RV 5 0 -GTC GAC TTG GCA TGC CAA GTT GAC GAT-3 0 . The amplified CD20 fragment and WPRE were ligated into a pCRII TOPO cloning vector (Invitrogen, Paisley, UK), according to the manufacturer's instructions, creating the following constructs: pCRII-CD20-BamHI-NotI, pCRII-CD20-BamHI-SalI, pCRII-WPRE-NotI-SalI.
Construction of CD20 retroviral vectors and generation of virus particles
The Moloney Murine leukemia virus (Mo-MuLV)-based vector pMX-a-IRES-b 37 was used for the insertion of the CD20 gene, WPRE and the insulator elements. The pMX-CD20 vector (CD20 vector) was generated by replacing the a-IRES-b fragment for the CD20 gene after digesting pMX-a-IRES-b and pCRII-CD20-BamHI-SalI with BamHI and SalI. The CD20W vector was generated by first inserting the CD20 gene from the pCRII-CD20 vector into the BamHI and NotI site of the pMX-a-IRES-b, substituting the a-fragment for the CD20 gene. Next, the IRES-b fragment was substituted for the WPRE element from pCRII-WPRE-NotI-SalI, by digesting with NotI and SalI. CD20-INS, CD20W-INS, CD20-ICE and CD20W-ICE vectors were generated as follows: the double copy of the insulator core element (ICE) and the 1.2 kb cHS4 insulator element (INS) were obtained from the pNI-CD expression vector by digesting with KpnI (ICE) or XbaI (INS). These fragments were blunted and cloned into the blunted 3 0 LTR NheI restriction site of the different CD20 retroviral vectors. CD20 virus particles were produced by calcium phosphate transfection of amphotropic Phoenix-packaging cells as previously described. 38 Viral titers were determined by serially diluted virus supernatant on CEM T cells.
Cell culture
The CEM T-cell line was cultured in RPMI (Gibco-BRL, Paisly, Scotland), 10% fetal calf serum (FCS, Integro, Zaandam, the Netherlands), penicillin (100 U/ml), streptomycin (100 mg/ml) (Gibco-BRL), 5 Â 10 À5 M 2-mercaptoethanol (Merck, Darmstadt, Germany), further called as culture medium. Amphotropic Phoenix cells were cultured in DMEM (Gibco-BRL), 10% FCS, penicillin, streptomycin and 2-mercaptoethanol. PBMCs were isolated by centrifugation through Ficoll (Amersham Pharmacia, Uppsala, Sweden) and stimulated with 300 U/ml human recombinant interleukin 2 (hurIL-2) (Proleukin, Chiron, Amsterdam, the Netherlands) for 24 h to generate ADCC effector cells. All cells were cultured at 371C in a 5% CO 2 atmosphere.
Flow cytometry and analysis CD20 expression was determined by monoclonal antibodies specific for the human CD20 molecule conjugated with fluorescein isothiocyanate (FITC) or phycoerythrin (PE) (BD Biosciences, San Jose, CA, USA). Monoclonal antibody anti-CD20 Mabthera (rituximab) was purchased from Roche. WinMDI 2.8 software was used to analyze CD20-expression level (mean fluorescence intensity, MFI) and homogeneity of expression of different membrane proteins. Homogeneity of CD20 expression was determined by the value of the percent coefficient of variation (CV).
Transduction of T cell lines, selection and clonal expansion
To study CD20 expression in T cells, CEM T cells were transduced with different viral supernatants. In a Costar 12-wells plate (Corning Incorporated, Cirus, USA), 10 5 cells were resuspended in 2 ml viral supernatant and culture medium (MOI of 1) in the presence 6 mg/ml of polybrene (Sigam-Alldrich, Steinheim, Germany). After culturing for 24 h, the infection medium was refreshed with 2 ml culture medium. Transduction efficiency was determined after 5 or 6 days of culture. CD20-positive transduced T cells were selected with monoclonal antibodies against CD20, conjugated with magnetic beads according to the manufacturer's instructions (Miltenyi Biotec, Bergisch Gladbach, Germany). CD20-positive cells were selected by passing the labelled cells through a magnetic cell sorting column using positive selection program on an autoMACS cell separation device (Miltenyi Biotec, Bergisch Gladbach, Germany).
RTX-mediated killing assays
For CDC assays, 10 6 CEM-CD20-positive cells were resuspended in various concentrations of human or rabbit serum with increasing concentration of RTX at 371C at different time points in a 5 ml Falcon tube (Becton Dickinson Labware, Franklin Lake, USA). Cells were washed twice with PBS and resuspended in 0.5 ml of PBS/1% BSA and propidium iodide (PI) (1 mg/ml), allowing the discrimination of living from dead cells. As negative controls, cells in the presence or absence of human serum with or without RTX were used.
The ADCC assay was based on a newly developed cytotoxicity assay by Jedema et al.
39 CD20-positive cells were washed in PBS and resuspended at 1.0 Â 10 6 cells/ ml. Next, the cells were stained with 5 mM of carboxyfluorescein diacetate succinimidyl ester (CFSE, Molecular Probes Europe BV, Leiden, The Netherlands) for 10 min at 371C. Subsequently, an equal volume of FCS was added and the cells were left at room temperature for 5 min. Cells were washed twice with PBS and the cell concentration was adjusted to 0.25 Â 10 6 cells/ml in culture medium. In all, 100 ml of the CD20-positive, CFSE-labelled cells were plated in 96 roundbottom microtiter plate per well in the absence or presence of Improved CD20 expression for efficient elimination of CD20-transgenic T cells T van Meerten et al added at 1:10 target/effector ratio (ADCC) or with 100 ml of human serum (CDC). To study the effect of ADCC and CDC on RTX-mediated cell killing, simultaneously both effector cells and human serum were added. After incubating the plates for 4 h at 371C, the wells were harvested and washed with PBS. Cells were resuspended in 200 ml of PBS, 1 mg/ml PI and 5000 Flow-Count Fluorospheres (Coulter Corporation, Miami, FL, USA) were added, allowing quantitative analysis of the cell populations using flow cytometry. In order to determine the absolute number of surviving cells, acquisition was stopped after taking up 2500 Fluorospheres and the CFSE-positive and PI-negative target cells were counted. The percentage RTX-mediated cell survival was calculated as follows:
%RTX Survival ¼ with RTX absolute viable CFSE þ PI À cells without RTX absolute viable CFSE þ PI À cells Â100
For all RTX-mediated killing experiments, three independent experiments were performed and all experiments were performed in triplicate.
Statistical analysis
Statistical analyses were performed with SPSS 11.5. To compare the homogeneity and MFI of CD20-positive cells transduced with the different CD20 vectors, a Dunnett's t-test was performed. A Student's t was used to analyze RTX-mediated cell kill of the cells transduced with the different constructs and the killing efficiencies of the different effector mechanisms. A P-value o0.05 is considered to be significant.
